Cipla v F Hoffmann-La Roche (2015)
High Court of Delhi·27 November 2015
Latest update: . Case: Hanmi Pharm Co Ltd v Controller General of Patents and Designs. Doctrine: Amendment Before the Controller.
Does failure to disclose foreign applications under section 8 always lead to revocation?
Under section 64(1)(m), noncompliance of Section 8 would not automatically result in revocation of the patent, for Section 64(1) is directory in nature.
Doctrine last updated on 12 November 2026
Non-disclosure or False Information Under Section 8, Ali on Patents, www.aop.onl/section-8-revocation
1An application or a patent may be opposed on the ground that the applicant/patentee has failed to disclose to the Controller the information required under s 8 or has furnished the information which in any material particular was false to his knowledge. A similar ground of revocation exists under s 64(1)(m). As per s 8, the applicant prosecuting an application for a patent in any country outside India in respect of the same or substantially the same invention shall disclose the same to the Controller and give an undertaking to keep him informed about subsequent filings of such application. The Controller may also require details about the processing of the application in that country which shall be furnished by the applicant. This provision takes care of fraudulent practices and false statements made by the applicant to the Controller.
2A patent may be revoked on the ground that the applicant for the patent has failed to disclose to the Controller the information required by s 8 of the Patents Act or has furnished information which, in any material particular, was false to his knowledge. A similar ground of opposition exists in ss 25(1)(h) and 25(2)(h).
3The expression ‘false to his knowledge’ implies that the false information is furnished intentionally and deliberately. It would exclude false information furnished by the applicant/patentee believing it to be true or pursuant to a bona fide mistake.
4A patent may be revoked if the applicant has failed to disclose to the Controller the information required by s 8 (for foreign applications) or has furnished information which was known to be false. Under s 8 of the Patents Act, the applicant prosecuting an application for a patent in any country outside India in respect of the same or substantially the same invention shall disclose the same to the Controller and give an undertaking to keep him informed about subsequent filings of such application. The controller may also require details about the processing of the application in that country which shall be furnished by the applicant.
5In Chemtura Corporation v Union of India (2009) the Delhi High Court held, in interlocutory proceedings, that the undertaking under s 8(1)(b) “did not hinge on the Controller asking for particulars but the applicant keeping the Controller informed ‘from time to time’. The expression ’time to time’ meant a periodicity of furnishing information akin to updating the Controller on the current status of the applications filed in other countries” (para 37), and that “Given this object of the provision there can be no two opinions that the disclosure has to be a periodic one and giving full particulars” (para 38). Of the Controller’s requirement under s 8(2) it held that “That requirement is mandatory” (para 40) and that “It cannot be said that the omission to comply with the requirement of Section 8 (2) was not serious enough to affect the decision of the Controller to grant the patent to the Plaintiff” (para 45), so that “the ground for revocation as contained in Section 64 (1) (m) is prima facie attracted” (para 49).
6In AstraZeneca v Intas Pharmaceuticals (2020), where “the plaintiffs did not provide to the Indian Patent Office, the office action/examination report dated 30.07.2002 issued by the USPTO” (para 31), the Delhi High Court held at the interlocutory stage that “These were vital documents which ought to have been furnished to the Indian Patent Office” (para 32.2), and that “The submission advanced on behalf of the plaintiffs that the terminal disclaimer is an obviation and not an admission of obviousness is not an answer to the provisions of Section 8(2) of the Act which is mandatory” (para 32.3). It held that the judgment in Sukesh Behl “was rendered in the context of Order XII Rule 6 of the Code of Civil Procedure, 1908” (para 32.4), and that the prosecution history “is an important factor to be taken into account at a preliminary injunction stage; at which point, the Court exercises equitable jurisdiction” (para 33.1).
7In F Hoffmann-La Roche v Cipla (2012) the Delhi High Court, after trial, held that “there is a mandatory provision provided u/s 8” (para 131), and that “It appears at this stage from the attending circumstances that the disclosure was not made and the said Section was in fact violated by the patentee and therefore the ground contained in Section 64(1)(m) is made out.” (para 154) It held that “still there lies a discretion to revoke or not to revoke” and that “solely on one ground of non-compliance of Section 8 of the Act by the plaintiffs, the suit patent cannot be revoked” (para 156), that “the usage of the word” “may” “under Section 64 confers a discretion of widest amplitude upon rectification Court” (para 196), that “the discretion tilts in favour of the plaintiffs and against the defendant” (para 199), and that “the party cannot be allowed to approbate or reprobate at the same time” (para 200).
8In Maj (Retd) Sukesh Behl v Koninklijke Phillips Electronics (2014), on an application for a decree on admission, a Division Bench of the Delhi High Court held that “it is no doubt true that it is mandatory to comply with the requirements under Section 8(1) of the Patents Act and non-compliance of the same is one of the grounds for revocation of the patents under Section 64(1)(m). However, the fact that the word ‘may’ is used in Section 64(1) itself indicates the intention of the legislature that the power conferred thereunder is discretionary.” It held that “the language of Section 64(1) is plain and unambiguous and it clearly confers a discretion upon the authority/Court while exercising the power of revocation” (para 37), and “that though any violation of the requirement under Section 8 may attract Section 64(1)(m) for revocation of the patent, such revocation is not automatic.” (para 38) Of Chemtura it held that “The question whether the power conferred under Section 64(1) of the Patents Act for revocation of the patent is discretionary or mandatory neither fell for consideration nor adjudicated by the Court in the said decision.” (para 39) Because “the power to revoke a patent under Section 64(1) is discretionary”, it was “necessary for the Court to consider the question as to whether the omission on the part of the plaintiff was intentional or whether it was a mere clerical and bonafide error” (para 40), and “The revocation would follow only if the Court is of the view that the omission to furnish the information was deliberate.” (para 49)
9In Cipla v F Hoffmann-La Roche (2015) the Division Bench held that “It is trite that a pleading concerning suppression of a fact or failure to disclose a relevant fact has to be specific by highlighting what was required to be disclosed or informed” (para 119), that “Section 64(1) is directory in nature and thus noncompliance of Section 8 would not automatically result in revocation of the patent” (para 124), and that “it is a case of substantial compliance inasmuch as even if Roche did not inform about the pending application resulting in grant of US ‘221, NATCO in its pre-grant opposition application to the suit patent duly informed about the same.” (para 126)
10In F Hoffmann-La Roche v Cipla (2009) the Division Bench asked “Should not an Applicant for a patent of a pharmaceutical product be bound to disclose the details of all other applications made by the Applicant for grant of patent of derivatives or forms of such product?” (para 34), and held that “The failure by the Plaintiffs to bring the above facts, to the notice of the Controller of Patents at the time of consideration of their application for patent for the compound of a combination of Polymorphs A and B was not consistent with the requirement of a full disclosure” (para 37).
11In Kudos Pharmaceuticals v Natco Pharma (2024), of the plea that Kudos had not disclosed that its Japanese applications “were facing rejection”, the Delhi High Court held at the interlocutory stage that “This, in my opinion, cannot be a basis, in any case, for Kudos to be regarded as disentitled to an injunction. At the very least, the matter would be a question of fact, to be decided on the facts of each individual case.” (para 68) It held that “in view of the explanation, this cannot be regarded as so overwhelming a factor as would justify rejection of the interim relief that Kudos seeks” (para 70).
12In Telefonaktiebolaget LM Ericsson v Intex Technologies (India) (2015) the Delhi High Court held at the interlocutory stage that “The purpose and object of Section 8 is that there should be full and true disclosure”, but that “it does not mean that the claims granted in every country have to be exactly the same”, that “So long as Indian Patent Office informed of all the major jurisdictions in which patents have been granted and substantial details are placed on record, the obligation of complying with Section 8 stands satisfied unless the Controller of Patents seeks some more detail(s)”, and that “The said Section should not be interpreted in the manner that every shred of paper filed in every foreign country has to be filed in the Indian Patent Office.” (para 103) It held that “Thus, even it is insufficient for defendant to contend that Section 8 has been violated without indicating the effect of alleged non-compliance or without showing lack of bonafide on part of plaintiff” (para 104), and that “The obligation of Section 8 cannot be so stressed in an action for infringement of patent is concerned” (para 105).
13In Merck Sharp and Dohme v Glenmark Pharmaceuticals (2015) the Division Bench held that “Section 8 only mandates the disclosure of patent applications outside India and not within” (para 75), and, of the contrary view taken in F Hoffmann-La Roche v Cipla (2009), that “this reading does not emanate from Section 8” (para 76).
14In Telefonaktiebolaget LM Ericsson v Lava International (2024) the Delhi High Court held after trial that “to successfully pursue the revocation of a patent on account of fraud or misrepresentation, it is essential to conclusively prove with cogent evidence that there has been deliberate or intentional misrepresentation(s) made by the patentee to the Indian Patents Office.” It held that “Mere allegations are not sufficient to revoke a patent; there must be a clear demonstration of intentional deceit”, and the claim under “Sections 64(1)(j) and 64(1)(m) of the Patents Act” was “found to be unsubstantiated and is therefore, rejected.” (para 123)
15In Intex Technologies (India) v Telefonaktiebolaget LM Ericsson (Publ) (2023) a Division Bench of the Delhi High Court, on appeal from the order at para 5C, held at the interlocutory stage that “Intex has failed to show how Ericsson has deliberately suppressed any information relevant under Section 8 of the Act from the Patent Controller.” (para 139) Following Merck v Glenmark, it held that the “Defendant is obligated to demonstrate how the breach of Section 8 provision is ‘patent and manifest’” (para 141), so that “the argument by Intex of a ‘Strict liability’ test for non-compliance of Section 8 is contrary to law” (para 142), and that “Intex has failed to show how non-production of any document by Ericsson was material to grant/non-grant of the patents.” (para 143) Of the second sub-section it held that “Section 8(2) of the Act required a Controller to call for the information it deemed relevant”, and, the Controller having made “no further demand”, that “no prima facie breach of obligation under Section 8(2) of the Act is made out.” (para 144)
High Court of Delhi·20 March 2015
High Court of Delhi·1 March 2024
High Court of Delhi·13 March 2015
High Court of Delhi·28 March 2024
High Court of Delhi·7 November 2014
Which grounds can be used to revoke an Indian patent?
Does section 8 require Form 3 disclosure of foreign applications filed after the Indian application?
Doctrine page · Written by Prof. Feroz Ali
www.aop.onl/section-8-revocation